CoChat

Effects of Intranasal Azelastine on the Response to Nasal Allergen Challenge

Saengpanich, Supinda, Assanasen, Paraya, deTineo, Marcy, Haney, Lauran, Naclerio, Robert M., Baroody, Fuad M. · 2002 · The Laryngoscope
Cited by 29

The DOI matches its Crossref record.

Abstract

Objectives/Hypothesis Azelastine, a second‐generation H 1‐receptor antagonist, is available for topical administration. The aim of the study was to evaluate the effects of topical intranasal azelastine on the early‐phase and the late‐phase allergic responses and on nasal hyper‐responsiveness to methacholine. Study Design Double‐blind, placebo‐controlled, two‐way crossover study in 20 subjects with seasonal allergic rhinitis, out of their allergy season. Methods Subjects were randomly assigned to receive either placebo or two puffs of azelastine twice a day (548 μg/d) for 2 weeks followed by nasal challenge with allergen. Twenty‐four hours later, while still receiving treatment, subjects underwent a nasal lavage and a nasal challenge with methacholine. End points included symptom scores, levels of mediators and number of eosinophils in nasal lavages, and the weight of secretions after methacholine challenge. Results Compared with placebo, treatment with intranasal azelastine resulted in significant reductions in allergen‐induced sneezing, rhinorrhea, itching, nasal congestion, and levels of albumin during the early‐phase response (P <.05). Azelastine had no effect on levels of histamine or tryptase during the early‐phase response. There was a significant eosinophil influx 24 hours after challenge, which was not inhibited by azelastine. Treatment with azelastine had no effect on the levels of albumin, interleukin‐4, interleukin‐5, intercellular adhesion molecule‐1, tumor necrosis factor‐α, and eosinophil cationic protein during the late‐phase response. However, azelastine did show a significant inhibitory effect on the methacholine response 24 hours after nasal allergen challenge (P <.05). Conclusions The effects of intranasal azelastine are similar to those of oral second‐generation antihistamines.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00005537-200201000-00009

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 29

Metadata

Authors
Saengpanich, S., Assanasen, P., deTineo, M., Haney, L., Naclerio, R. M., & Baroody, F. M.
Venue
The Laryngoscope
Publisher
Wiley
Published
2002-01
Volume
112
Issue
1
Pages
47-52
ISSN
  • 0023-852X (ISSN-L)
  • 1531-4995
OpenAlex
W2018358366
Cited by
29
References
0
FWCI
1.03
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of Intranasal Azelastine on the Response to Nasal Allergen Challenge. https://app.cochat.ai/papers/10.1097/00005537-200201000-00009
The paper
Saengpanich, S., Assanasen, P., deTineo, M., Haney, L., Naclerio, R. M., & Baroody, F. M. (2002). Effects of Intranasal Azelastine on the Response to Nasal Allergen Challenge. The Laryngoscope. https://doi.org/10.1097/00005537-200201000-00009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.